Tends to reduce weight gain in early postmenopausal Women
10:1719-1726 (2015) Shibai A, Takahashi Y, Ishizawa Y, Motooka D, Nakamura S, Ying B-W, Tsuru S
Latest Reviews Been using this for about 3 weeks now and my skin texture has noticeably improved
Here are a few ways future formulations could shift the market: Oral (Rybelsus 2.0, better semaglutide formulations) What changes: Easier to prescribe and adhere to, but worse tolerability Where it moves: Into primary care lower friction, tighter payer control Strategic shift: More access, same adherence problem Risk: Higher churn, more side-effect driven dropout Next-gen combos (e.g., GLP-1 + GIP + amylin, muscle-sparing) What changes: Better outcomes, better tolerability Where it moves : Into specialist-aligned care models deeper payer integration Strategic shift: Drugs become platforms unlock long-term value Risk: Slow coverage without strong RWE